The Rise of Mesenchymal Stem Cells in Oncology

 Cancer researchers can improve and hone cell and gene therapy choices to provide individualised medical treatments through the immunomodulatory properties of mesenchymal stem cells. Cancer medicine and therapy developers can alter the functioning of the cells to promote cancer suppression by utilising mesenchymal stem cells' capacity to modify the tumour microenvironment. Mesenchymal stem cells, for instance, present a route to deliver anti-cancer medications to tumour locations due to their propensity to move to tumours. Additionally, researchers can control mesenchymal stem cells via antibody treatment and modify the angiogenesis process, which cancers depend on to thrive.



Immunomodulatory effects of MSCs

The immunomodulatory characteristics of MSCs offer researchers a powerful weapon against cancer, serving as the foundation for immunotherapy. The development of immune system cells such macrophages, dendritic cells, T cells, B cells, and natural killer cells (NK cells), which can control and suppress malignant cells, from mesenchymal stem cells is a possibility. 


Mesenchymal stem cells can stimulate T cells, making them useful in the development of CAR-T cell therapy, potentially a more successful type of cell therapy for cancer. The capacity of mesenchymal stem cells to preferentially locate and move to tumour areas offers the possibility of enhancing the activity of CAR-T cells intended to eradicate cancer via modified T cells.


The Role of Gene and Cell Therapy

Mesenchymal stem cells can be successfully used in cancer gene therapies in conjunction with cell therapies. Genes can be delivered by MSCs like how medications can be sent by them to tumour sites. Mesenchymal stem cells can be given genetic material that will change the way that living tumour cells behave or behave differently, and they can then deliver this therapy by recognising and migrating to tumour sites. Additionally, MSCs can be genetically altered to produce particular proteins that are designed to combat cancer.


It is also possible to use the interaction between mesenchymal stem cells and other cells in the tumour microenvironment, specifically cancer stem cells, to treat cancer. Hindering the two types of cells' ability to communicate with one another may help to reduce the number of cancer stem cells, reduce medication resistance in tumours, and minimise the capacity of cancers to metastasise and/or grow. Exosomes, a kind of extracellular vesicle that MSCs and CSCs use to communicate, can be employed by researchers to destroy cancer stem cells.


Finally, treating cancer with mesenchymal stem cells is not limited to preventing it. The potential of mesenchymal stem cells to create tissue to repair tumour-damaged bones can also be used in regenerative medicine.


If you are a researcher working in academia or industry and looking for Mesenchymal stem cells and cancer cells for your research, get in touch with us at info@kosheeka.com or call/WhatsApp at +91-9654321400

Comments

Post a Comment

Popular posts from this blog

Dealing With Contaminated Cell Lines: Don’t Miss Your Data

Image
The reproducibility and validity of scientific findings are shaped by a multitude of factors, and precise experimental methodologies, as well as the use of identical experimental substances where applicable, must be recorded. Reproducibility necessitates the characterization of reagents to assure their purity. Cell culture is an essential component of current biomedical research. Multiple quality control techniques, including cell line identification and validation that cell lines are not contaminated, are essential to assuring that reported data is reproducible. Cell line authentication is required to guarantee that cell lines have not been unintentionally incorrectly labelled or cross-contaminated, which could contribute to incorrect disease model interpretations. The necessity of quality control of cell lines used in scientific research cannot be overstated, as it is vital for data reproducibility. Two major hazards in tissue culture are: 1.        Cell Line Authentication: The
Read more

From Tissues to Treatment: How Sarcoma and Carcinoma Differ in Origin and Progression

Image
  When it comes to understanding cancer, it is crucial to recognize the various types and their distinct characteristics. Two major categories of cancer that often arise in medical discussions are sarcoma and carcinoma. While both originate in different types of tissues, their progression, treatment options, and prognosis can significantly vary. In this blog, we will explore the origins of sarcoma and carcinoma and their unique progression patterns, and discuss how these differences impact their treatment approaches. Understanding Sarcoma Sarcoma is a type of cancer that develops from connective tissues, including bones, muscles, cartilage, blood vessels, and soft tissues. Unlike carcinoma, which typically originates from epithelial cells, sarcomas arise from mesenchymal cells . This distinction in tissue origin gives rise to notable differences in how sarcomas progress and spread. Origin and Progression of Sarcoma Sarcomas often begin in the supporting structures of the body, such as
Read more

The Power of Mouse Liver Fractions

Image
  The goal of every drug discovery is to develop safe and effective medications. To achieve this crucial goal, a key step involves studying the metabolism of drugs in order to understand their potential toxicity and effectiveness. Even before we start preclinical trials on human primary cells or animals, we need to test the drugs in vitro to ensure their safety and efficacy. One major step forward is the use of mouse liver subcellular fractions. Why are these fractions important? New drugs need to be safe and effective. Part of this safety check involves understanding how our bodies metabolize the drug. These mouse hepatocyte S9 fractions mimic the human liver's metabolic machinery, helping researchers predict how a drug will be processed in the body. We have three types of fractions, namely S9, microsome, and cytosol, that can offer a significant understanding to improve drug discovery. Think of these fractions as specialized teams within the liver cell, each with a specific role
Read more